About 1 in 4 people with treatment-resistant depression may achieve remission with repetitive transcranial magnetic stimulation (rTMS), according to data collected from patients at five hospitals in France. The analysis, which was published in the Journal of Affective Disorders, also showed that patients with more severe symptoms at baseline experienced greater improvements following rTMS on average.
“To the best of our knowledge, this is the largest naturalistic study [of rTMS] with clinician-rated scales by … psychiatrists,” wrote Noomane Bouaziz, M.D., of EPS Ville Evrard in Neuilly-sur-Marne, France, and colleagues. “Our study encompasses a large variety of stimulation settings and comorbidities, reflecting usual clinical practice. Thus, this study is intended to guide psychiatrists in real-life practice, as a complement to [randomized, controlled trials] with strict inclusion criteria.”
Read the full article at PsychNews.org